Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) traded up 2.8% during mid-day trading on Tuesday . The stock traded as high as $7.09 and last traded at $6.91. 2,594,212 shares changed hands during mid-day trading, a decline of 28% from the average session volume of 3,598,576 shares. The stock had previously closed at $6.72.
Wall Street Analyst Weigh In
Several research firms recently weighed in on TLRY. Canaccord Genuity Group began coverage on shares of Tilray Brands in a research report on Tuesday, January 27th. They set a "hold" rating for the company. Weiss Ratings reiterated a "sell (d-)" rating on shares of Tilray Brands in a research note on Wednesday, January 21st. TD Cowen decreased their target price on Tilray Brands from $10.00 to $7.00 and set a "buy" rating on the stock in a research report on Monday, March 30th. Roth Mkm raised Tilray Brands from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research note on Thursday, April 2nd. Finally, ATB Cormark Capital Markets dropped their price target on Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating for the company in a research report on Thursday, April 2nd. Three equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $11.50.
Check Out Our Latest Stock Report on Tilray Brands
Tilray Brands Stock Performance
The stock has a 50-day moving average of $7.11 and a 200 day moving average of $9.93. The stock has a market cap of $805.06 million, a PE ratio of -0.51 and a beta of 2.00. The company has a quick ratio of 1.66, a current ratio of 2.79 and a debt-to-equity ratio of 0.19.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.10). The company had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. Tilray Brands had a negative return on equity of 3.31% and a negative net margin of 156.51%.During the same period last year, the business earned ($0.87) earnings per share. Equities analysts predict that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.
Hedge Funds Weigh In On Tilray Brands
Several institutional investors and hedge funds have recently bought and sold shares of the company. Hilton Head Capital Partners LLC acquired a new stake in shares of Tilray Brands during the 4th quarter worth approximately $38,000. Schonfeld Strategic Advisors LLC lifted its holdings in Tilray Brands by 4.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company's stock valued at $1,304,000 after acquiring an additional 6,182 shares during the last quarter. IFP Advisors Inc lifted its holdings in Tilray Brands by 14.3% in the fourth quarter. IFP Advisors Inc now owns 60,318 shares of the company's stock valued at $545,000 after acquiring an additional 7,541 shares during the last quarter. Integrated Wealth Concepts LLC grew its position in Tilray Brands by 33.8% in the third quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company's stock worth $64,000 after acquiring an additional 9,341 shares during the period. Finally, CreativeOne Wealth LLC increased its stake in Tilray Brands by 12.2% during the third quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company's stock worth $151,000 after acquiring an additional 9,452 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.